CUE Stock Forecast: All the More Reason to Consider Cue Biopharma Inc (CUE) Now

Cue Biopharma Inc (NASDAQ: CUE) is -47.54% lower on its value in year-to-date trading and has touched a low of $0.45 and a high of $3.25 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CUE stock was last observed hovering at around $1.16 in the last trading session, with the day’s gains setting it 0.22%.

Currently trading at $1.38, the stock is 122.77% and 105.77% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.32 million and changing 19.40% at the moment leaves the stock -13.39% off its SMA200. CUE registered -37.89% loss for a year compared to 6-month loss of -32.11%. The firm has a 50-day simple moving average (SMA 50) of $0.67308 and a 200-day simple moving average (SMA200) of $1.59908.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a 134.75% gain in the last 1 month and extending the period to 3 months gives it a 48.92%, and is 82.91% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 25.43% over the week and 15.02% over the month.

Cue Biopharma Inc (CUE) has around 53 employees, a market worth around $83.39M and $8.30M in sales. Profit margin for the company is -566.02%. Distance from 52-week low is 207.78% and -57.37% from its 52-week high. The company has generated returns on investments over the last 12 months (-181.51%).

The EPS is expected to grow by 37.16% this year.

Cue Biopharma Inc (CUE) Top Institutional Holders

96.0 institutions hold shares in Cue Biopharma Inc (CUE), with institutional investors hold 23.19% of the company’s shares. The shares outstanding are 60.21M, and float is at 59.65M with Short Float at 5.96%. Institutions hold 23.06% of the Float.

The top institutional shareholder in the company is BLEICHROEDER LP with over 2.86 million shares valued at $3.55 million. The investor’s holdings represent 5.7849% of the CUE Shares outstanding. As of 2024-06-30, the second largest holder is SLATE PATH CAPITAL LP with 2.4 million shares valued at $2.98 million to account for 4.8567 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 2.03 million shares representing 4.1066% and valued at over $2.52 million, while BLACKROCK INC. holds 1.5298 of the shares totaling 0.76 million with a market value of $0.94 million.